このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Zevra Therapeutics マネジメント
マネジメント 基準チェック /04
現在、CEO に関する十分な情報がありません。
主要情報
Neil McFarlane
最高経営責任者
US$3.4m
報酬総額
| CEO給与比率 | 4.6% |
| CEO在任期間 | less than a year |
| CEOの所有権 | n/a |
| 経営陣の平均在職期間 | 1.4yrs |
| 取締役会の平均在任期間 | 1.2yrs |
経営陣の近況
Recent updates
Analysts Just Shaved Their Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Forecasts Dramatically
Apr 07
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Just Reported And Analysts Have Been Cutting Their Estimates
Apr 04Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) Stock Retreats 27% But Revenues Haven't Escaped The Attention Of Investors
Apr 02Investors Appear Satisfied With Zevra Therapeutics, Inc.'s (NASDAQ:ZVRA) Prospects
Dec 28Bullish: Analysts Just Made A Noticeable Upgrade To Their Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Forecasts
Sep 05This Just In: Analysts Are Boosting Their Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Outlook for This Year
Aug 20Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable
Apr 17US$18.00: That's What Analysts Think Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Is Worth After Its Latest Results
Mar 10Is Zevra Therapeutics (NASDAQ:ZVRA) Using Debt In A Risky Way?
Mar 08Bearish: Analysts Just Cut Their KemPharm, Inc. (NASDAQ:KMPH) Revenue and EPS estimates
Nov 16Does KemPharm (NASDAQ:KMPH) Have A Healthy Balance Sheet?
Nov 11KemPharm posts Phase 1 data to support further studies for sleep disorder therapy
Sep 28KemPharm wins Buy rating at Canaccord on CNS focus
Sep 15KemPharm - Redesigning Approved Drugs For Better Efficacy And Safety
Jun 28KemPharm exercises existing warrants and issues new ones in private placement
Jun 18KemPharm reports orange book listing for six U.S. patents covering serdexmethylphenidate
May 26CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$49m |
| Dec 31 2023 | US$3m | US$158k | -US$46m |
報酬と市場: Neilの 総報酬 ($USD 3.45M ) は、 US市場 ($USD 1.58M ) の同規模の企業の平均を上回っています。
報酬と収益: Neilの報酬と会社の業績を比較するにはデータが不十分です。
CEO（最高経営責任者
Neil McFarlane (51 yo)
less than a year
在職期間
US$3,445,231
報酬
Mr. Neil F. McFarlane serves as President & Chief Executive Officer at Zevra Therapeutics, Inc. since October 10, 2023 and serves as its Director since October 9, 2023. He has served as Director at Collegi...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | less than a year | US$3.45m | データなし | |
| Co-Founder & Chief Development Officer | no data | US$1.67m | 0.065% $ 121.1k | |
| CFO, Secretary & Treasurer | 9yrs | US$2.26m | 0.038% $ 70.7k | |
| Chief Commercial Officer & Executive VP of Business Development | 1.4yrs | US$1.82m | 0.0084% $ 15.6k | |
| Chief Scientific Officer | 1.4yrs | US$1.08m | 0.0066% $ 12.2k | |
| Vice President of Investor Relations & Corporate Communications | 1.8yrs | データなし | データなし | |
| Senior Vice President of Manufacturing | 1.4yrs | データなし | データなし | |
| Senior Vice President of Clinical Development | 1.4yrs | データなし | データなし | |
| Senior Vice President of Medical Affairs & Advocacy | 1.4yrs | データなし | データなし | |
| Chief Medical Officer | less than a year | データなし | データなし | |
| Senior VP & Corporate Controller | 7.3yrs | データなし | 0.011% $ 19.8k |
1.4yrs
平均在職期間
51.5yo
平均年齢
経験豊富な経営陣: ZVRAの経営陣は 経験豊富 とはみなされません ( 1.4年の平均在職年数)。これは新しいチームを示唆しています。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | less than a year | US$3.45m | データなし | |
| Independent Director | 1.2yrs | US$274.00k | 0% $ 0 | |
| Independent Director | 1.2yrs | US$258.02k | 0% $ 0 | |
| Independent Chair | 2.8yrs | US$324.39k | 0.0017% $ 3.2k | |
| Member of Scientific and Medical Advisory Board | no data | データなし | データなし | |
| Independent Director | 1.2yrs | US$264.31k | 0.048% $ 89.0k | |
| Independent Director | 1.2yrs | US$260.67k | 0.0024% $ 4.5k | |
| Chairman of Scientific and Medical Advisory Board | 17.4yrs | データなし | データなし | |
| Member of Scientific & Medical Advisory Board | no data | データなし | データなし | |
| Co-Chair of Physician Advisory Council | 10.7yrs | データなし | データなし | |
| Co-Chair of Physician Advisory Council | 10.7yrs | データなし | データなし | |
| Independent Director | less than a year | US$243.04k | 0.024% $ 44.5k |
1.2yrs
平均在職期間
58yo
平均年齢
経験豊富なボード: ZVRAの 取締役会 は 経験豊富 ではない ( 1.2年の平均在任期間) ため、新しい取締役会が必要であると考えられます。